TANG KEVIN

Average Profitability
144.13%
Insider Buys Quantity
33
Insider Buys Sum
$172.21M
Insider Sells Quantity
13
Insider Sells Sum
$232.53M

Insider Activity of TANG KEVIN

According to the SEC Form 4 filings, TANG KEVIN, being in a position of

  1. 10 percent owner at Singular Genomics Systems, Inc.,
    оver the last 12 months, has bought 122416 shares for $1.81M, and sold 0 shares,
    over all time since 2024-09-16, has bought 122416 shares for $1.81M, and sold 0 shares.

The largest purchase of all time was on 2017-01-19 and amounted to 4918032 shares of Heron Therapeutics, Inc. for $60M.

The largest sale of all time was on 2018-09-12 and amounted to 5390000 shares of Heron Therapeutics, Inc. for $192.69M.

Biography of TANG KEVIN

No biography is available at this moment.

2024-09-18PurchaseSingular Genomics Systems, Inc.
OMIC
10 percent owner
32,000
1.3143%
$17.21$550,720-8.67%
2024-09-17PurchaseSingular Genomics Systems, Inc.
OMIC
10 percent owner
40,000
1.5204%
$15.33$613,200-4.83%
2024-09-16PurchaseSingular Genomics Systems, Inc.
OMIC
10 percent owner
50,416
2.0091%
$12.74$642,300+20.06%
2021-11-23SaleAptevo Therapeutics Inc.
APVO
921,336
12.987%
$11.25$10.37M-73.69%
2021-11-22SaleAptevo Therapeutics Inc.
APVO
10 percent owner
255,331
5.9122%
$7.03$1.8M-30.86%
2021-11-19SaleAptevo Therapeutics Inc.
APVO
10 percent owner
213,800
4.7422%
$7.59$1.62M-38.63%
2021-11-18SaleAptevo Therapeutics Inc.
APVO
10 percent owner
369,533
8.1153%
$8.34$3.08M-44.69%
2020-11-06PurchaseAptevo Therapeutics Inc.
APVO
10 percent owner
348,554
7.5668%
$22.73$7.92M+8.23%
2020-11-05PurchaseAptevo Therapeutics Inc.
APVO
10 percent owner
1.25M
25.0765%
$18.78$23.5M+20.82%
2020-11-04PurchaseAptevo Therapeutics Inc.
APVO
10 percent owner
1.27M
24.3464%
$14.34$18.27M+50.91%
2019-10-04PurchaseHeron Therapeutics, Inc.
HRTX
director
571,428
0.3221%
$8.75$5M+2.41%
2018-09-12SaleHeron Therapeutics, Inc.
HRTX
5.39M
7.0856%
$35.75$192.69M-29.59%
2018-03-29PurchaseHeron Therapeutics, Inc.
HRTX
384,616
0.5598%
$26.00$10M+8.51%
2017-02-23PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
10 percent owner
134,200
3.3648%
$4.34$582,079-53.33%
2017-01-19PurchaseHeron Therapeutics, Inc.
HRTX
4.92M
8.5734%
$12.20$60M+10.47%
2015-06-10PurchaseHeron Therapeutics, Inc.
HRTX
242,424
0.6699%
$24.75$6M-11.71%
2015-06-02PurchaseHeron Therapeutics, Inc.
HRTX
64,790
0.2146%
$23.84$1.54M+12.42%
2015-06-01PurchaseHeron Therapeutics, Inc.
HRTX
4,760
0.0121%
$19.30$91,868+6.98%
2015-05-29PurchaseHeron Therapeutics, Inc.
HRTX
230,450
0.7416%
$19.74$4.55M+31.96%
2014-06-25PurchaseHeron Therapeutics, Inc.
HRTX
1.02M
4.2484%
$11.75$12M-19.42%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.